MMAF (Monomethyl Auristatin F) is a synthetic anti-tumor agent known for its antimitotic properties, derived as an auristatin derivative. This compound acts as an antitubulin agent, blocking cell division by inhibiting the polymerization of tubulin, a crucial protein for cell division. MMAF has found its application as a cytotoxic payload in antibody-drug conjugates (ADCs) aimed at targeted cancer therapy.
Besides MMAF, TBD offers an array of MMAF derivatives and linkers suitable for diverse ADC-related applications. Refer to the examples section for a list of production-ready solutions.
For further details or inquiries regarding other solutions, feel free to contact us directly.